The Cancer Biomarker Market is on track for significant growth, with a projected market size of USD 27.4 billion by 2030. This substantial increase from USD 11.1 billion in 2022 reflects a Compound Annual Growth Rate (CAGR) of 12.0% during the forecast period (2023-2030). Key Players The major key players are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., QIAGEN...